Galux
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies.
HQ: Dogokdong, Seoul-t’ukpyolsi, South Korea
Country: South Korea

Establishment Year:
2020

Company Stage:
Initial Revenues

Estimated Employees:
11 .. 50

Estimated Revenues
$M 2.00

Raised Funding:
$M 36.28

AI Categories: